Prenetics Global (PRE)
Sells IM8 nutrition products and CircleDNA consumer genetic testing worldwide.
$22.87
After-hours close−0.02 (−0.08%)
At close$22.89(−5.96%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 5 | 6 | 6 | 8 | 10 | 17 | 18 | 24 | 37 | 36 | 46 |
| Cost of revenue | 3 | 3 | 3 | 2 | 4 | 7 | 10 | 10 | 10 | 15 | 13 | 16 |
| Gross profit | 2 | 3 | 4 | 4 | 4 | 4 | 7 | 7 | 14 | 22 | 23 | 30 |
| 15 | 14 | 13 | 14 | 16 | 20 | 18 | 17 | 20 | 34 | 33 | 52 | |
| Research & development | 4 | 2 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
| 12 | 9 | 11 | 12 | 13 | 19 | 16 | 16 | 19 | 29 | 32 | 51 | |
| Selling & marketing | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 5 | 10 | 14 | 22 | 41 |
| General & administrative | 11 | 8 | 9 | 10 | 11 | 17 | 11 | 10 | 10 | 15 | 9 | 10 |
| Other expenses | −2 | 3 | −1 | −1 | 0 | −1 | 0 | 0 | 0 | 5 | 0 | 0 |
| Operating income | −13 | −11 | −9 | −11 | −12 | −17 | −11 | −10 | −6 | −12 | −10 | −22 |
| 1 | −3 | 0 | −1 | 0 | −8 | 0 | −1 | −1 | −16 | −18 | 13 | |
| Interest income | 0 | 4 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | −1 | 3 | 0 | 0 | 0 | 8 | 0 | 1 | 1 | 16 | 0 | 0 |
| Income before tax | −12 | −15 | −9 | −11 | −12 | −25 | −11 | −11 | −7 | −28 | −27 | −9 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | −7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −12 | −15 | −9 | −11 | −12 | −18 | −11 | −11 | −7 | −28 | −27 | −9 |
| Discontinued operations | −2 | −3 | 0 | 0 | 0 | 0 | 0 | −2 | −2 | 0 | 4 | 0 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −14 | −17 | −9 | −11 | −11 | −16 | −10 | −12 | −7 | −28 | −23 | −9 |
| EPS, basic | −$1.16 | −$1.40 | −$0.70 | −$0.88 | −$0.84 | −$1.29 | −$0.80 | −$0.94 | −$0.53 | −$1.75 | −$1.36 | −$0.52 |
| EPS, diluted | −$1.16 | −$1.40 | −$0.70 | −$0.88 | −$0.84 | −$1.29 | −$0.80 | −$0.94 | −$0.53 | −$1.75 | −$1.36 | −$0.52 |
| Weighted average shares, basic | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 14 | 16 | 17 | 17 |
| Weighted average shares, diluted | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 14 | 16 | 17 | 17 |
| EBITDA | −12 | −15 | −9 | −10 | −11 | −25 | −11 | −11 | −7 | −25 | −10 | −22 |
| Depreciation & amortization | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 4 | 0 | 0 |
| EBIT | −12 | −15 | −9 | −11 | −12 | −25 | −11 | −11 | −7 | −28 | −10 | −22 |
